現有回應

• Asdfgh標記此篇為：❌ 含有不實訊息

  理由

  Sarah Gilbert 沒有放棄「專利權」，目前是牛津大學擁有疫苗的獨家權利。
  他們跟 AstraZeneca 的協議是：在新冠肺炎大流行期間，要以成本價出售 AZ 疫苗至少30億劑，之後繼續出售的疫苗，牛津大學則按照協議收取權利金，如果病毒流感化，這個收益可以幫助大學進行更多
  
  閱讀更多

  出處

  https://www.wsj.com/articles/oxford-deve⋯_Wf8_ERHq_IPHACaJTj23gHYFBZhIi180r-jGGVA
  
  
  https://innovation.ox.ac.uk/technologies⋯ng/expedited-access-covid-19-related-ip/
  
  https://healthpolicy-watch.news/ip-not-t⋯ng-pharma-execs-at-who-press-conference/
  
  
  https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686
  
  https://www.reuters.com/article/us-health-coronavirus-who-ip-idUSKBN2B0269

  Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money

  https://www.wsj.com/articles/oxford-developed-covid-vaccine-then-scholars-clashed-over-money-11603300412?fbclid=IwAR1DXmkBHLA7ybIHoAc_Wf8_ERHq_IPHACaJTj23gHYFBZhIi180r-jGGVA

  An early deal with Merck was scotched for fear poor countries would be left out; now the university could make over $100 million with AstraZeneca if the technology succeeds.

  Expedited access for COVID-19 related IP - Oxford University Innovation

  https://innovation.ox.ac.uk/technologies-available/technology-licensing/expedited-access-covid-19-related-ip/

  The COVID-19 pandemic demands an urgent and unprecedented response. University research and expertise is critical ...

  https://healthpolicy-watch.news/ip-not-the-main-barrier-to-equitable-vaccine-rollout-say-two-leading-pharma-execs-at-who-press-conference/

  Cannot get data from URL

  Subscribe to read | Financial Times

  https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686

  News, analysis and comment from the Financial Times, the worldʼs leading global business publication

  Waiving patents alone won't solve COVID-19 vaccine access: developers

  https://www.reuters.com/article/us-health-coronavirus-who-ip-idUSKBN2B0269

  Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a

• 章王科標記此篇為：❌ 含有不實訊息

  理由

  原始的新聞只講到他在溫布頓被感謝，沒講到他放棄專利(詳連結1)
  實際上他不認為放棄專利有注疫情,更多廠商研發疫苗才是(詳連結2)
  另外AZ便宜的原因是這個公司聲明在疫情期間不以獲利為目標(詳連結3)

  出處

  連結1 新聞稿
  https://www.independent.co.uk/news/uk/ho⋯ovid-vaccine-sarah-gilbert-b1874316.html
  連結2 他不認為放棄專利有注疫情,更多廠商研發疫苗才是
  https://healthpolicy-watch.news/ip-not-t⋯ng-pharma-execs-at-who-press-conference/
  連結3 AZ公司聲明在疫情期間不以獲利為目標
  https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686

  Wimbledon crowd gives standing ovation to Oxford Covid vaccine developer

  https://www.independent.co.uk/news/uk/home-news/wimbledon-covid-vaccine-sarah-gilbert-b1874316.html

  Tennis fans show support for vaccine scientists and keyworkers on first day at Centre Court

  https://healthpolicy-watch.news/ip-not-the-main-barrier-to-equitable-vaccine-rollout-say-two-leading-pharma-execs-at-who-press-conference/

  Cannot get data from URL

  Subscribe to read | Financial Times

  https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686

  News, analysis and comment from the Financial Times, the worldʼs leading global business publication

• H PAs標記此篇為：❌ 含有不實訊息

  理由

  關於專利權的訊息查不到相關內容，三月時還有Gilbert認為放棄專利對疫苗普及不會有幫助的新聞，可見後面將放棄專利ㄧ疫苗價格ㄧ作連結的方有可質疑之處

  出處

  https://www.reuters.com/article/us-health-coronavirus-who-ip-idUSKBN2B0269

  Waiving patents alone won't solve COVID-19 vaccine access: developers

  https://www.reuters.com/article/us-health-coronavirus-who-ip-idUSKBN2B0269

  Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a

• Chicco Huang標記此篇為：⭕ 含有正確訊息

  理由

  牛津大學網站的確說明釋出有條件的COVID疫苗智財權。

  出處

  https://innovation.ox.ac.uk/technologies⋯ng/expedited-access-covid-19-related-ip/

  Expedited access for COVID-19 related IP - Oxford University Innovation

  https://innovation.ox.ac.uk/technologies-available/technology-licensing/expedited-access-covid-19-related-ip/

  The COVID-19 pandemic demands an urgent and unprecedented response. University research and expertise is critical ...

• LiangLiang Lo標記此篇為：⚠️️ 不在查證範圍

  理由

  是真的!!
  https://en.wikipedia.org/wiki/Sarah_Gilbert
  第41項

增加新回應

• 撰寫回應
• 使用相關回應 1
• 搜尋

你可能也會對這些類似文章有興趣